Sunny Drugs And Pharmaceuticals Limited
Pharmaceutical company offering a wide range of medicinal products and goods.
1989 | Delhi (India) | Active
Sunny Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 8.74 M
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 M
- Revenue Growth %
- Profit Growth 47.99%
- Ebitda 83.75%
- Net Worth -0.71%
- Total Assets -0.06%
About Sunny Drugs And Pharmaceuticals
Sunny Drugs And Pharmaceuticals Limited (SDAPL) is a Public Limited Indian Non-Government Company incorporated in India on 11 October 1989 and has a history of 35 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 8.74 M.
The company currently has active open charges totaling ₹2.30 M.
Manohar Khanna, Naresh Puri, and Brij Kant serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1989PLC037985
- Company No.
037985
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Sunny Drugs And Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Khanna  | Director | 21-Dec-1992 | Current |
| Naresh Puri | Director | 21-Dec-1992 | Current |
| Brij Kant | Director | 29-Mar-2019 | Current |
Financial Performance of Sunny Drugs And Pharmaceuticals.
Sunny Drugs And Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 47.99% increase in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunny Drugs And Pharmaceuticals?
In 2018, Sunny Drugs And Pharmaceuticals had a promoter holding of 81.17% and a public holding of 18.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.23 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bombay Mucantile Co-Op. Bank Ltd. : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 1994 | Bombay Mucantile Co-Op. Bank Ltd. | ₹2.30 M | Open |
How Many Employees Work at Sunny Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Sunny Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunny Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunny Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
